+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

Antipsychotic Drugs: Technologies and Global Markets - Product Thumbnail Image

Antipsychotic Drugs: Technologies and Global Markets

  • Report
  • September 2018
  • 174 Pages
  • Global
From
Neurodegenerative Diseases Therapeutics Market 2024-2028 - Product Thumbnail Image

Neurodegenerative Diseases Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 155 Pages
  • Global
From
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 269 Pages
  • Global
From
Central Nervous System Treatment Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Central Nervous System Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 110 Pages
  • Global
From
Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030 - Product Thumbnail Image

Fragile X Syndrome Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2030

  • Drug Pipelines
  • February 2022
  • 60 Pages
  • Global
From
Neurodegenerative Disorder Therapeutics Global Market Report 2024 - Product Thumbnail Image

Neurodegenerative Disorder Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Autism Spectrum Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Autism Spectrum Disorders Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Estrogen Receptor Beta Partial Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Anti-Parkinson Drugs Global Market Report 2024 - Product Thumbnail Image

Anti-Parkinson Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Neurodegenerative Diseases Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neurodegenerative Diseases Drugs Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Vascular Dementia - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Dementia - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028 - Product Thumbnail Image

Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast - 2028

  • Report
  • February 2020
  • 253 Pages
  • Global
From
Neurologic Disorders Therapeutics Market 2022-2026 - Product Thumbnail Image

Neurologic Disorders Therapeutics Market 2022-2026

  • Report
  • May 2022
  • 120 Pages
  • Global
From
Alzheimer's Therapeutics Market by Drug Class, Type, Distribution - Global Forecast 2025-2030 - Product Thumbnail Image

Alzheimer's Therapeutics Market by Drug Class, Type, Distribution - Global Forecast 2025-2030

  • Report
  • October 2024
  • 183 Pages
  • Global
From
Parkinson's Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Parkinson's Disease Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 88 Pages
  • Global
From
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • March 2019
  • 220 Pages
  • Global
From
Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Parkinson's Disease Market: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • May 2018
  • 204 Pages
  • Global
From
Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024 - Product Thumbnail Image

Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

  • Report
  • September 2024
  • 450 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1150 Pages
  • Global
From
Loading Indicator